Drinking red wine in
moderation lowers estrogen levels and elevates testosterone possibly
stemming growth of cancer cells
Drinking red wine in moderation may reduce
one of the risk factors for breast cancer, providing a natural weapon
to combat a major cause of death among U.S. women, new research
from Cedars-Sinai Medical Center shows.
The study, published online in the Journal of Women's Health, challenges
the widely held belief that all types of alcohol consumption heighten
the risk of developing breast cancer. Doctors long have determined
that alcohol increases the body's estrogen levels, fostering the
growth of cancer cells.
But the Cedars-Sinai study found that chemicals in the skins and
seeds of red grapes slightly lowered estrogen levels while elevating
testosterone among premenopausal women who drank eight ounces of
red wine nightly for about a month.
White wine lacked the same effect.
Researchers called their findings encouraging, saying women who
occasionally drink alcohol might want to reassess their choices.
"If you were to have a glass of wine with dinner, you may
want to consider a glass of red," said Chrisandra Shufelt,
M.D., assistant director of the Women's Heart Center at the Cedars-Sinai
Heart Institute and one of the study's co-authors. "Switching
may shift your risk."
In the Cedars-Sinai study, 36 women were randomized to drink either
Cabernet Sauvignon or Chardonnay daily for almost a month, then
switched to the other type of wine. Blood was collected twice each
month to measure hormone levels.
Researchers sought to determine whether red wine mimics the effects
of aromatase inhibitors, which play a key role in managing estrogen
levels. Aromatase inhibitors are currently used to treat breast
cancer.
Investigators said the change in hormone patterns suggested that
red wine may stem the growth of cancer cells, as has been shown
in test tube studies.
Co-author Glenn D. Braunstein, M.D., said the results do not mean
that white wine increases the risk of breast cancer but that grapes
used in those varieties may lack the same protective elements found
in reds.
"There are chemicals in red grape skin and red grape seeds
that are not found in white grapes that may decrease breast cancer
risk," said Braunstein, vice president for Clinical Innovation
and the James R. Klinenberg, M.D., Chair in Medicine.
The study will be published in the April print edition of the Journal
of Women's Health, but Braunstein noted that large-scale studies
still are needed to evaluate the safety and effectiveness of red
wine to see if it specifically alters breast cancer risk. He cautioned
that recent epidemiological data indicated that even moderate amounts
of alcohol intake may generally increase the risk of breast cancer
in women. Until larger studies are done, he said, he would not recommend
that a non-drinker begin to drink red wine.
The research team also included C. Noel Bairey Merz, M.D., director
of the Women's Heart Center, director of the Preventive and Rehabilitative
Cardiac Center and the Women's Guild Chair in Women's Health, as
well as researchers from the University of Southern California Keck
School of Medicine and Hartford Hospital in Connecticut.
|